Search
Aminomethylbenzoic acid
go.drugbank.com/drugs/DB13244ExperimentalAminomethylbenzoic acid may be useful as an antifibrinolytic agent [A174994].
BIIB015
go.drugbank.com/drugs/DB06304InvestigationalIt has been investigated for the treatment of subjects with relapsed or refractory solid tumours.
Mavoglurant
go.drugbank.com/drugs/DB13004InvestigationalMavoglurant has been used in trials studying the treatment of Patient Diagnosed With OCD and and Resistant to SSRI Treatment (Failed SSRI Over 12 Weeks at Appropriate Doses).
MK-0767
go.drugbank.com/drugs/DB12055InvestigationalMK0767 has been used in trials studying the treatment of Dyslipidemia, Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes Mellitus, Type 2, and Diabetes Mellitus, Type II, among others.
Binetrakin
go.drugbank.com/drugs/DB12182InvestigationalBinetrakin has been used in trials studying the treatment of HIV Infections, Sarcoma, Kaposi, Non-Hodgkin's Lymphoma (NHL), Myelodysplastic Syndrome (MDS), and Leukemia, Acute Myelogenous (AML), among
Eleclazine
go.drugbank.com/drugs/DB12394InvestigationalEleclazine has been used in trials studying the treatment of LQT2 Syndrome, Long QT Syndrome, Ischemic Heart Disease, Ventricular Arrhythmia, and Long QT Syndrome Type 3, among others.
Afacifenacin
go.drugbank.com/drugs/DB21385ExperimentalThe usage of the INN stem '-fenacin' in the name indicates that Afacifenacin is a muscarinic receptor antagonist. Afacifenacin has a monoisotopic molecular weight of 481.2 Da.
Fosifidancitinib
go.drugbank.com/drugs/DB21462ExperimentalThe usage of the INN stem '-citinib' in the name indicates that Fosifidancitinib is a Janus kinase inhibitor. Fosifidancitinib has a monoisotopic molecular weight of 505.12 Da.
Gemnelatinib
go.drugbank.com/drugs/DB21513ExperimentalThe usage of the INN stem '-tinib' in the name indicates that Gemnelatinib is a tyrosine kinase inhibitor. Gemnelatinib has a monoisotopic molecular weight of 524.23 Da.
Girocitinib
go.drugbank.com/drugs/DB21692ExperimentalThe usage of the INN stem '-citinib' in the name indicates that Girocitinib is a Janus kinase inhibitor. Girocitinib has a monoisotopic molecular weight of 326.14 Da.